Collegium to Participate in Upcoming Investor Conference
Rhea-AI Summary
Collegium Pharmaceutical, a specialty pharmaceutical company focused on responsible pain management, will participate in the Jefferies Virtual Healthcare Conference on June 2, 2021, at 4:30 PM ET. The event will feature a fireside chat format, and the presentation will be accessible via live webcast on the company’s investor website. A replay will be available for about 30 days post-event. Collegium's headquarters is located in Stoughton, Massachusetts, and they aim to lead in pain management solutions.
Positive
- None.
Negative
- None.
News Market Reaction – COLL
In the trading session that priced this news, COLL gained 2.46%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
STOUGHTON, Mass., May 20, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conference:
Jefferies Virtual Healthcare Conference
Format: Fireside chat
Date: Wednesday, June 2, 2021
Time: 4:30 PM Eastern Time
The presentation will be webcast live and may be accessed from the Investor section of the Company’s website: https://ir.collegiumpharma.com. A replay of the webcast will be available on the Company’s website for approximately 30 days after the event.
About Collegium Pharmaceutical, Inc.
Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.
Contact:
Alex Dasalla
adasalla@collegiumpharma.com